论文部分内容阅读
目的:探讨前列地尔联合左卡尼汀对慢性肾功能衰竭合并心功能衰竭的治疗效果。方法:选择本院2014年1月-2015年1月收治的100例慢性肾功能衰竭合并心功能衰竭患者为观察对象,随机将其分为对照组和观察组,两组患者均接受常规治疗,观察组在此基础上接受前列地尔联合左卡尼汀治疗,回顾分析两组观察对象临床治疗效果。结果:观察组经过临床治疗后胱抑素C、血肌酐(Scr)、血尿素氮(BUN)、末端脑钠肽(pro-BNP)以及射血分数(EF)等观察指标均优于对照组(P<0.05),临床治疗总有效率高于对照组(P<0.05)。结论:慢性肾功能衰竭合并心功能衰竭患者在常规治疗的基础上,接受前列地尔联合左卡尼汀治疗,具有较为满意的临床效果。
Objective: To investigate the therapeutic effect of alprostadil combined with levocarnitine on patients with chronic renal failure and heart failure. Methods: A total of 100 patients with chronic renal failure and heart failure who were treated in our hospital from January 2014 to January 2015 were selected as the observation subjects and randomly divided into control group and observation group. Both groups received routine treatment, The observation group received alprostadil combined with levocarnitine on this basis, and the clinical effects of the two groups were retrospectively analyzed. Results: The observation group was better than the control group in the observation group after the treatment of cystatin C, serum creatinine (Scr), blood urea nitrogen (BUN), pro-BNP and ejection fraction (P <0.05). The total effective rate of clinical treatment was higher than that of the control group (P <0.05). Conclusion: Chronic renal failure patients with heart failure, on the basis of routine treatment, are treated with alprostadil in combination with levocarnitine, which has a satisfactory clinical effect.